Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer — Sponsor Intelligence | 31 EU Trials

Filter these 31 trials by condition, phase, country and more.

Open in Search →

31 Registered trials

16 Recruiting

7 Completed trials

5 Countries active

56 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase I

Phase III: 3 Phase II/III: 1 Phase II: 9 Phase IV: 12 Phase I: 4 Phase I (Other): 1 Phase I (FiH): 1

Oversight events:

2 temporary halts across 2 trials

View oversight register →

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Complications of transplanted liver 1 Endocarditis bacterial 1 Multiple sclerosis 1 Primary effusion lymphoma 1 Alcoholic liver disease 1 Burkitt's lymphoma refractory 1 Colorectal cancer 1 Device related infection 1 Intraductal papillary mucinous neoplasm 1 Plasmablastic lymphoma 1 Triple negative breast cancer 1 Burkitt's lymphoma recurrent 1

Top IMPs

AMOXICILLIN 1 ATEZOLIZUMAB 1 AUTOLOGOUS GENETICALLY MODIFIED T LYMPHOCYTES TRANSDUCED WITH LENTIVIRUS EXPRESSING CAR PROTEIN DIRECTED AGAINST BCMA 1 AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS 1 BEVACIZUMAB 1 BUDESONIDE 1 BUPIVACAINE HYDROCHLORIDE 1 EPINEPHRINE 1 FLUDEOXYGLUCOSE (18F) 1 GADOTERIC ACID 1 HUMAN SERUM ALBUMIN 1 IZAFLORTAUCIPIR (18F) 1

All trials

31 total

A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po… Not authorised

2025-521052-35-00 Phase I (FiH) 1 country
Aspiration of duodenopancreatic juice after secretin stimulation (ADPJsecr-) vs endoscopic aspiration (EUS-FNA) for molecular analysis of in… Pending

2024-519972-21-00 Phase III 1 country SECRETIN SYNTHETIC HUMAN
Randomized controlled study comparing conventional antibiotic regimens versus antimicrobial strategies guided by epidemiological surveillanc… Pending

2024-519974-38-00 Phase IV 1 country NORFLOXACIN
Evaluation of patients with total coronary occlusions with multimodality image. Pending

2024-519979-26-00 Phase IV 1 country GADOTERIC ACID; REGADENOSON; THEOPHYLLINE ANHYDROUS
LOCAL INVASIVE TREATMENT OF TRAPEZIUS MUSCLE PAIN IN PATIENTS WITH FIBROMYALGIA Pending

2024-520345-23-00 Phase IV 1 country BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM CHLORIDE; TRIAMCINOLO…
Adductor canal and IPACK (infiltration between the popliteal artery and the capsule of the knee) blocks versus genicular nerves block for to… Pending

2025-523071-34-00 Phase IV 1 country EPINEPHRINE; ROPIVACAINE HYDROCHLORIDE
Application of radiomics for diagnosis and follow-up of cardiovascular device infections: PREDICT study Pending

2025-524624-21-00 Phase IV 1 country FLUDEOXYGLUCOSE (18F)
CD5CAR-NK cells for refractory invasive mold disease Pending

2025-524638-24-00 Phase I 1 country
LIVER AKI: A trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with … Recruiting

2025-521457-16-00 Phase IV 1 country
HER2DX-guided diagnostic treatment For patients with HER2-positive early-stage breast cancer Recruiting

2025-521040-37-00 Phase III 4 countries TRASTUZUMAB, PERTUZUMAB
Efficacy and tolerability of a simethicone-containing evacuating solution for colorectal cancer screening colonoscopy: a randomized parallel… Recruiting

2025-523748-11-00 Phase IV 1 country SIMETICONE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM CITRATE, SODIUM SULFATE …
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer Recruiting

2025-521460-36-00 Phase IV 1 country
A phase II, randomized, open-label, national, multicenter study evaluating the efficacy and safety of the combination of atezolizumab and be… Recruiting

2025-521459-22-00 Phase II 1 country ATEZOLIZUMAB; BEVACIZUMAB
Darbepoetin in patients candidates for liver transplant: randomized clinical trial Recruiting

2025-521701-41-00 Phase IV 1 country
First in human pilot study to assess the safety and efficacy of dendritic cells loaded with frameshift derived neopeptides for the preventio… Recruiting

2025-521109-42-00 Phase I 1 country
Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs). Recruiting

2024-511915-21-01 Phase I 1 country
Clinical trial for the use of a humanized CART directed against BCMA (ARI0002h) in patients with newly diagnosed primary plasma cell leukemi… Recruiting

2024-515053-21-00 Phase II 1 country AUTOLOGOUS GENETICALLY MODIFIED T LYMPHOCYTES TRANSDUCED WITH LENTIVIRUS EXPRESS…
Molecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels Recruiting

2023-505245-13-00 Phase IV 3 countries
Quantification tools for a novel tau PET marker in a rare neurological disease: 18F-PI-2620 in progressive supranuclear palsy Recruiting

2023-508718-40-00 Phase II 1 country IZAFLORTAUCIPIR (18F)
Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis Recruiting

2024-519969-21-00 Phase IV 1 country AMOXICILLIN
Efficacy of IMP reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled cl… Recruiting

2024-519968-41-00 Phase II/III 1 country SIMVASTATIN
Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled … Recruiting

2024-513600-33-00 Phase IV 1 country
Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy Recruiting

2024-513601-31-00 Phase II 1 country VARNIMCABTAGENE AUTOLEUCEL
First in human study of the infusion of ARI0003 cells in relapsed/refractory to treatment B-cell aggressive lymphoma Recruiting

2023-507213-97-00 Phase I 1 country

Showing 1–24 of 31 trials

← All sponsors A–Z